Metabolic Bone Diseases Flashcards
Most common metabolic bone disease in the US
osteoporosis
Released from parathyroid in response to low Ca+ level and activate kidney, bones, GI system
PTH
Released from thyroid in response to elevated serum Ca
calcitonin
Biggest medication category linked to osteoporosis as a side effect
steroids
Standard test for the evaluation of bone mineral density
DEXA scan
What age should everyone receive a DEXA scan regardless of risk factors?
women > 65 and men > 70
Bone mineral density compared to what is normally expected in a young healthy adult (at their peak BMD) based on gender
T-score
What T-scare indicates osteroporosis?
less than -2.5
Used in the following populations compared to other ppl of matched ages/sex/race: Premenopausal women, Men younger then 50 years, Children
z-score
What z-score is considered “below the expected range for age?”
-2.0
Effective at predicting femoral neck, hip and spine fractures. Lower cost than DXA. Portable. No exposure to radiation
Quantitative calcaneal ultrasonography
What imaging should women btw 65-69 and men btw 75-79 receive if their T-score is -1.5?
vertebral imaging
Symptoms of osteoporosis
gradual loss of height and Dowager’s hump
Nonpharmacologic treatment of osteoporosis
calcium, vit D, excercise
Which calcium supplement is better when patient is using H2 blockers/PPIs?
calcium citrate
Which calcium supplement is less like to cause kidney stones?
calcium citrate
Drug of choice for osteoporosis or Paget’s after failure of conservative treatment
bisphosphonates
Name the bisphosphonates
alendronate (Fosamax), Risedronate (Actonel), Zoledronic acid (Reclast), Ibandronate (Boniva)
Inhibit bone resorption by decreasing the number and function of osteoclasts
bisphosphonates
What do you need to correct before starting treatment with bisphosphonates?
calcium and vitamin D
CI to oral bisphosphonates
Barretts, upper GI dz, esophagitis, GFR < 35
Atypical fractures associated with bisphosphonates
subtrochanteric and lateral femur fx
Horrifying side effect of bisphosphonates
osteonecrosis of jaw
How long might you continue therapy for a patient who is high risk (T-score <3.5)?
10 yrs
Indicated for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis
Estrogen agonist/antagonist (SERMs)
Name the SERM mentioned in Jen’s lecture
Raloxifene (Evista)
approved for the treatment of osteoporosis in women ≥5 years post menopause. Has not been shown to reduce nonvertebral fractures
calcitonin (miaclcin or fortical)
What allergy is a CI to calcitonin treatment?
salmon
Only if failed other non-estrogen treatment options. 5 yrs of therapy. Started with 10 yrs of menopause
Hormone replacement therapy (HRT)- Prempro
For severe osteoporosis when other treatments have failed. stimulates bone formation also approved for use in men
Parathyroid hormone: Teriparatide (Forteo)
Area most commonly involved with Pagets disease
axial skeleton
Increased rate of bone remodeling. Overgrowth of bone at single or multiple sites. Impaired integrity of affected bone. Onset after 55
paget’s (Osteitis deformans)
Cancer associated with Paget’s
osteosarcoma
Increased lab result with Pagets
alkaline phosphatase
Test of choice for Pagets. Show increased bone remodeling and blood flow
bone scan
Decreased mineralization of newly formed bone. Bone is soft but no loss of bone matrix
osteomalacia
Two main causes of osteomalacia
hypocalcemia and hypophosphatemia
Common symptoms of osteomalacia
bone pain, muscle weakness, bone tenderness, fracture
Most common imaging finding of osteomalacia
reduced bone density with thinning of the cortex
Cortical infarctions
wide transverse lucencies traversing bone usually at right angles to the involved cortex. Associated most frequently with osteomalaciaand rickets
Looser’s fractures
Where are fractures most commonly located in osteomalacia?
distal radius and proximal femur
Major contributor to renal osteodystrophy
secondary hyperparathyroidism
high turnover secondary to hyperparathyroidism
osteitis fibrosis
low turnover, most common CKD related bone disease, due to suppression of the parathyroid glands
adynamic bone disease
low turnover with abn mineralization, not that common in CKD
osteomalacia
either high or low turnover and abnormal mineralization
mixed osteodystrophy